Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A new partnership will unite expertise, infrastructure and data across borders to accelerate diagnosis, treatment and ultimately prevention of major diseases – starting with women’s health, infectious diseases and pandemic preparedness.

People representing the four Alliance partners across France and the UK:
Dr Jean Susini, Director General, Synchrotron SOLEIL. Sir Thomas Drew KCMG, His Majesty’s Ambassador to France.  Prof Richard Cornall,  Head of Nuffield Department of Medicine, University of Oxford.  Prof Matthieu Resche-Rigon, Dean of the Health Faculty, Université Paris Cité. Jean-Luc Moullet, Director General for Research and Innovation, French Ministry of Higher Education, Research and Space. Dr Martin Walsh, Deputy Director of Life Sciences, Diamond Light Source.  Dr Odette Tomescu-Hatto, Director of International Affairs, Institut Pasteur. © The Department for Science, Innovation and Technology (DSIT)

The partnership, signed by the University of Oxford, Université Paris Cité, the Institut Pasteur, Diamond Light Source and Synchrotron SOLEIL, comes at a time when advances in science and technology are generating unprecedented amounts of biological and clinical data and transforming understanding of human health. But turning that information into faster diagnoses, better treatments and improved disease prevention remains a major challenge across disciplines, institutions and national systems.

The new UK-France Strategic Interdisciplinary Alliance in Health and AI (Health Alliance) has been established to help bridge those gaps by connecting world-leading expertise and national infrastructure that are rarely integrated within a single collaboration.

Leading the Alliance work on behalf of Oxford’s Nuffield Department of Medicine, Professor Philippe Guérin said the partnership would allow researchers to “understand how infections develop, spread and respond to treatment” by combining “advanced imaging, data and biological science” in new ways.

Professor Guérin added that bringing together “the technology of two of the world’s most powerful synchrotrons, with the world’s greatest research minds” would help researchers study disease “at an unprecedented level of detail”, driving “innovation in diagnostics and therapies” while strengthening preparedness for future health threats worldwide. 

Read the full story on the Nuffield Department of Medicine website.